V. De Sanctis, “The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in β-thalassemia patients”, Acta Biomed, vol. 93, no. 2, p. e2022162, May 2022, doi: 10.23750/abm.v93i2.12056.